| Literature DB >> 33806154 |
Miroslaw Zajac1, Elise Dreano2,3, Aurelie Edwards4, Gabrielle Planelles3,5, Isabelle Sermet-Gaudelus2,3,6,7,8.
Abstract
Knowledge on the mechanisms of acid and base secretion in airways has progressed recently. The aim of this review is to summarize the known mechanisms of airway surface liquid (ASL) pH regulation and their implication in lung diseases. Normal ASL is slightly acidic relative to the interstitium, and defects in ASL pH regulation are associated with various respiratory diseases, such as cystic fibrosis. Basolateral bicarbonate (HCO3-) entry occurs via the electrogenic, coupled transport of sodium (Na+) and HCO3-, and, together with carbonic anhydrase enzymatic activity, provides HCO3- for apical secretion. The latter mainly involves CFTR, the apical chloride/bicarbonate exchanger pendrin and paracellular transport. Proton (H+) secretion into ASL is crucial to maintain its relative acidity compared to the blood. This is enabled by H+ apical secretion, mainly involving H+/K+ ATPase and vacuolar H+-ATPase that carry H+ against the electrochemical potential gradient. Paracellular HCO3- transport, the direction of which depends on the ASL pH value, acts as an ASL protective buffering mechanism. How the transepithelial transport of H+ and HCO3- is coordinated to tightly regulate ASL pH remains poorly understood, and should be the focus of new studies.Entities:
Keywords: ATP12A; CFTR; SLC26A4; lung; pH
Year: 2021 PMID: 33806154 PMCID: PMC8037888 DOI: 10.3390/ijms22073384
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1PRISMA flow diagram.
Figure 2Pseudo-stratified airway epithelium and physiological role of main cells.
Airway surface liquid (ASL) pH in animal models.
| Sample/Model | pH Value | Method Reference | ||
|---|---|---|---|---|
| WT | CF | |||
| Mouse | 6.95 ± 0.03 | 6.84 ± 0.07 | BCECF-dextran | [ |
| 7.14 ± 0.01 (in vivo) | BCECF-dextran | [ | ||
| 6.98 ± 0.16 | pH electrode | [ | ||
| 7.28 | BCECF-dextran | [ | ||
| Rat | 7.25 ± 0.05 | 6.42 ± 0.12 | Not specified | [ |
| Ferret | 6.84 ± 0.03 | pH electrode | [ | |
| Rabbit * | 6.92 ± 0.01 | pH electrode | [ | |
| Cow | 6.81 ± 0.04 (25 mM bicarbonate) | BCECF-dextran | [ | |
| 6.98 ± 0.05 (no bicarbonate) | BCECF-dextran | [ | ||
| Pig | 7.14 ± 0.04 | 6.94 ± 0.05 | Optode (in vivo) | [ |
| Primary Bronchial epithelia | 7.37 ± 0.05 | 7.05 ± 0.03 | SNARF pH indicator | [ |
| 6.93 ± 0.04 | pH electrode | [ | ||
| ~7.1 | 7.2 | pH electrode | [ | |
| Gland fluid | 6.9 ± 0.06 | BCECF-dextran | [ | |
* alveolar subphase; WT: Wild Type; CF: Cystic Fibrosis.
ASL pH in vitro measurements of human samples.
| Sample/Model | pH Value | Method | Reference | |
|---|---|---|---|---|
| WT | CF | |||
| Cell lines | ||||
| CFBE41σ | 7.42 ± 0.02 * | 7.15 ± 0.01 * | pH electrode | [ |
| 7.24 ** | X Ray microanalysis | [ | ||
| 16HBE14 σ | 7.14 ± 0.02 | pH electrode | [ | |
| 7.16 ** | pH electrode | [ | ||
| Calu3 | ~7.2 | BCECF-dextran | [ | |
| 7.55 ± 0.04 | 7.28 ± 0.02 | pH electrode | [ | |
| NuLi-1/CuFi-1 | 7.52 ± 0.07 | 6.88 ± 0.02 | SNARF pH indicator | [ |
| C38/IB3-1/ | 7.32 ± 0.08 | 7.02 ± 0.04 | pH electrode | [ |
| Primary cells (bronchi) | ||||
| 6.81 ± 0.20 | BCECF-dextran | [ | ||
| 6.6 ± 0.1 | SNARF-1 | [ | ||
| ΔpH = −0.096 ± 0.029 * | ΔpH = −0.146 ± 0.011 * | pH electrode | [ | |
| ~7.4 | ~7.1 | BCECF-dextran | [ | |
| 7.77 | 7.31 | pH electrode | [ | |
| 7.35 ± 0.09 | pH electrode | [ | ||
| 7.43 ± 0.06 * | 7.26 ± 0.02 * | pH electrode | [ | |
| 7.35 ± 0.05 | 6.70 ± 0.03 | pH electrode | [ | |
| Submucosal gland secretions | ||||
| 7.18 ± 0.06 | 6.57 ± 0.09 | BCECF-dextran | [ | |
| 6.97 ± 0.06 | BCECF-dextran | [ | ||
* after 6 h Ringer incubation; ** after 3 h Ringer incubation; WT: Wild Type; CF: Cystic Fibrosis.
ASL pH in vivo measurements of human samples in healthy controls and patients with cystic fibrosis.
| Sample/Model | pH Value | Method | Reference | |
|---|---|---|---|---|
| WT | CF | |||
| Nose | ||||
| Edge of nostril/adults | 5.5 ± 0.1 | 5.6 ± 0.1 | Monocrystalline antimony catheter | [ |
| 4 cm from nares/adults | 6.7 ± 0.13 | 6.2 ± 0.1 | Monocrystalline antimony catheter | [ |
| 6.6 ± 0.1 | 6.8 ± 0.10 | Gold probe | [ | |
| 5 to 7.2 * | Mobidium pH probe | [ | ||
| Neonates | 6.4 ± 0.2 | 5.2 ± 0.3 (4.5–6.9) | Mobidium pH probe | [ |
| Lower airway/children | ||||
| 7.1 ± 0.1 | 7.1 ± 0.2 | Gold probe | [ | |
| 7.00 ± 0.12 | 6.98 ± 0.15 | Fiberoptic probe | [ | |
*: different genotypes; WT: Wild Type; CF: Cystic Fibrosis.
ASL pH in vivo measurements of human samples in patients with diseases other than cystic fibrosis.
| pH Value | Method | Reference | |
|---|---|---|---|
| Pneumonia | 6.62 ± 0.07 | pH electrode | [ |
| 6.72 | pH electrode | [ | |
| Chronic lung diseases | 6.64 ± 0.08 | pH electrode | [ |
| COPD | 6.21 ± 0.37 | pH test strip | [ |
| Acute exacerbation of COPD (AECOPD) | 6.89 ± 0.53 | pH test strip | [ |
| Chronic rhinosinusitis | 6.7 ± 0.6 | pH electrode | [ |
| Pulmonary tuberculosis (sputum) | 7.00 (range 5.50–8.37) | pH electrode | [ |
| Chronic bronchitis | 7.59 (mucoid) | pH electrode | [ |
| 7.83 (purulent) | pH electrode | [ | |
| Rhinitis | 7.2–8.3 | pH electrode | [ |
COPD: Chronic Obstructive Broncho Pulmonary Disease.
Figure 3Distribution of the currently known acid and base transporters of airway epithelial cells.